Harnal-D (tamsulosin hydrochloride 0.2 mg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Harnal-D (tamsulosin hydrochloride 0.2 mg), covering 2018-06-19 to 2018-06-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study Assessing a Range of Formulations of the Fixed Dose Combination Product Containing Dutasteride (0.5mg) and Tamsulosin Hydrochloride (0.2mg) to Find a Formulation Which is Bioequivalent to Harnal-D Tablets (Tamsulosin Hydrochloride, 0.2mg) in Healthy Male Subjects From North East Asia [Phase 1]